OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Benefit-Cost Analysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It	25
Incidence and Costs of Personal and Property Crimes in the USA, 2017	19
The Value of Statistical Life: A Meta-Analysis of Meta-Analyses	11
Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis	10
Extending the Domain of the Value of a Statistical Life	10
Economic Activity and the Value of Medical Innovation during a Pandemic	10
Addressing Fundamental Uncertainty in Benefit–Cost Analysis: The Case of Deep Seabed Mining	9
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation	8
Valuing COVID-19 Morbidity Risk Reductions	6
Economic Evaluation of Investments in Airports: Recent Developments	6
The Welfare Cost of Vaccine Misallocation, Delays and Nationalism	6
Open Access in Scientific Information: Sustainability Model and Business Plan for the Infrastructure and Organization of OpenAIRE	5
How is the U.S. Pricing Carbon? How Could We Price Carbon?	5
Promoting Equity through Equitable Risk Tradeoffs	4
The Benefits and Costs of a Child Allowance	4
Risk-Informed Benefit–Cost Analysis for Homeland Security R&D: Methodology and an Application to Evaluating the Advanced Personal Protection System for Wildland Firefighters	3
Improving Learning in Low- and Lower-Middle-Income Countries	3
Paying a Premium for “Green Steel”: Paying for an Illusion?	3
Early Education and Adult Health: Age 37 Impacts and Economic Benefits of the Child-Parent Center Preschool Program	3
Inequality and the Value of a Statistical Life	3
Quantifying the Non-Use Value of Biodiversity in Cost–Benefit Analysis: The Dutch Biodiversity Points	3
Is California’s Electric Vehicle Rebate Regressive? A Distributional Analysis	3
Benefit-Cost Ratios of Continuing Routine Immunization During the COVID-19 Pandemic in Africa	3
Time Savings vs. Access-Based Benefit Assessment of New York’s Second Avenue Subway	3
Accounting for the Effects of Employment, Equity, and Risk Aversion in Cost–Benefit Analysis: An Application to an Adaptation Project	3

Distributional weighting and welfare/equity tradeoffs: a new approach	3
An Equity Blindspot: The Incidence of Regulatory Costs	3
Cost–Benefit Assessment of Public Investments in France: The Use of Counter-Experts	3
Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model	2
Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries	2
The Influence of Individual Characteristics and Institutional Norms on Bureaucrats’ Use of Cost–Benefit Analysis: A Choice Experiment	2
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research	2
A Benefit-Cost Analysis of Increased International Migration of Skilled Labor in Africa and the World	2
Dynamic Versus Static Modeling of Mortality-Related Benefits of PM_2.5 Reductions in the USA and Chile: 1990 to 2050	2
The Weak Spot of Infrastructure BCA: Cost Overruns in Seven Road and Railway Construction Projects	2
Discounting in Natural Resource Damage Assessment	2
Methodological Challenges in Estimating the Lifetime Medical Care Cost Externality of Obesity	2
The Investment Case for Land Tenure Security in Sub-Saharan Africa: A Cost–Benefit Analysis	2
Institutional Roles and Goals for Retrospective Regulatory Analysis	1
Benefit–Cost Analysis of Increased Funding for Agricultural Research and Development in the Global South	1
A Test of Hirschman’s Hiding Hand Principle in World Bank-Financed Hydropower Projects	1
The Benefits and Costs of Automotive Regulations for Low-Income Americans	1
One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond	1
Achieving Maternal and Neonatal Mortality Development Goals Effectively: A Cost-Benefit Analysis	1
Seven Recommendations for Pricing Greenhouse Gas Emissions	1
The Investment Case for E-Government Procurement: A Cost–Benefit Analysis	1
The Elasticity of Marginal Utility of Income for Distributional Weighting and Social Discounting: A Meta-Analysis	1
Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio	1
Poverty, Irrationality, and the Value of Cash Transfers	1
The Broad Impacts of Disposable Lighter Safety Regulations	1
Investing in Nutrition: A Global Best Investment Case	1
Benefit-Cost Analysis for Climate Action	1
“We Test”: An Imagined Regulatory Future	1